New York State Common Retirement Fund
TVRD

New York State Common Retirement Fund’s Tvardi Therapeutics TVRD Stock Holding History

New York State Common Retirement Fund’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$9.51K – 3360
2026
Q1 		$9.51K Hold
3,000
– – ﹤0.01% 3084
2025
Q4 		$13K Hold
3,000
– – ﹤0.01% 3126
2025
Q3 		$108K Sell
3,000
-1,000
-25% -$28.5K ﹤0.01% 2582
2025
Q2 		$92K Buy
+4,000
New +$94.6K ﹤0.01% 2736
2024
Q3 		– Sell
-11
Closed -$104 – 3367
2024
Q2 		$104 Sell
11
-444
-98% -$10.6K ﹤0.01% 3391
2024
Q1 		$14.9K Sell
455
-11
-2% -$285 ﹤0.01% 3168
2023
Q4 		$12.5K Buy
466
+8
+2% +$331 ﹤0.01% 3182
2023
Q3 		$27.7K Buy
458
+13
+3% +$1.22K ﹤0.01% 3145
2023
Q2 		$45.3K Buy
445
+1
+0.2% +$138 ﹤0.01% 3144
2023
Q1 		$78.5K Sell
444
-417
-48% -$140K ﹤0.01% 2884
2022
Q4 		$333K Buy
861
+139
+19% +$52.8K ﹤0.01% 2512
2022
Q3 		$243K Buy
722
+149
+26% +$54K ﹤0.01% 2680
2022
Q2 		$188K Sell
573
-305
-35% -$107K ﹤0.01% 2820
2022
Q1 		$384K Sell
878
-10
-1% -$4.11K ﹤0.01% 2518
2021
Q4 		$389K Sell
888
-3
-0.3% -$1.51K ﹤0.01% 2573
2021
Q3 		$495K Sell
891
-185
-17% -$92.8K ﹤0.01% 2470
2021
Q2 		$553K Buy
1,076
+9
+0.8% +$5.7K ﹤0.01% 2543
2021
Q1 		$834K Hold
1,067
– – ﹤0.01% 2201
2020
Q4 		$581K Hold
1,067
– – ﹤0.01% 2282
2020
Q3 		$489K Hold
1,067
– – ﹤0.01% 2224
2020
Q2 		$657K Hold
1,067
– – ﹤0.01% 2079
2020
Q1 		$507K Hold
1,067
– – ﹤0.01% 2028
2019
Q4 		$619K Sell
1,067
-2
-0.2% -$1.4K ﹤0.01% 2183
2019
Q3 		$704K Buy
1,069
+83
+8% +$69K ﹤0.01% 2167
2019
Q2 		$763K Buy
986
+133
+16% +$93.4K ﹤0.01% 2154
2019
Q1 		$602K Hold
853
– – ﹤0.01% 2215
2018
Q4 		$399K Buy
853
+17
+2% +$11K ﹤0.01% 2381
2018
Q3 		$721K Hold
836
– – ﹤0.01% 2261
2018
Q2 		$576K Hold
836
– – ﹤0.01% 2391
2018
Q1 		$373K Hold
836
– – ﹤0.01% 2479
2017
Q4 		$368K Hold
836
– – ﹤0.01% 2490
2017
Q3 		$412K Hold
836
– – ﹤0.01% 2449
2017
Q2 		$463K Buy
836
+142
+20% +$90.1K ﹤0.01% 2444
2017
Q1 		$460K Buy
694
+150
+28% +$80.1K ﹤0.01% 2417
2016
Q4 		$182K Hold
544
– – ﹤0.01% 2802
2016
Q3 		$164K Hold
544
– – ﹤0.01% 2831
2016
Q2 		$94K Hold
544
– – ﹤0.01% 3011
2016
Q1 		$122K Buy
544
+86
+19% +$25.7K ﹤0.01% 2879
2015
Q4 		$278K Hold
458
– – ﹤0.01% 2595
2015
Q3 		$236K Buy
458
+94
+26% +$62.9K ﹤0.01% 2697
2015
Q2 		$159K Buy
+364
New +$141K ﹤0.01% 2996

Other funds holding TVRD

DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

New York State Common Retirement Fund's TVRD Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Tvardi Therapeutics (TVRD) in Q2 2026, closing a stake of 3,000 shares — an estimated $9.51K sold.

New York State Common Retirement Fund first reported a position in TVRD in Q2 2015 and held it in 41 quarters. The position peaked at $834K in Q1 2021. 13 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining Tvardi Therapeutics position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 3,000 Tvardi Therapeutics shares in Q2 2026, an estimated $9.51K.
  • New York State Common Retirement Fund first reported a position in Tvardi Therapeutics in Q2 2015 and held it in 41 quarters.
  • New York State Common Retirement Fund's Tvardi Therapeutics position peaked at $834K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.